BSX vs EOLS · P/E 20, rev $16.75B vs rev $266.3M
Boston Scientific Corp (BSX) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the BSX and EOLS stock pages for the full models.
Not investment advice.